Comparison of TAP Block and Intraperitoneal Ropivacaine for Pain Relief and Early Recovery After Laparoscopic Surgeries.
- Conditions
- Medical and Surgical,
- Registration Number
- CTRI/2025/04/085339
- Lead Sponsor
- Mahatma Gandhi University of Medical Sciences and Technology
- Brief Summary
This is a prospective, hospital based, comparative study to compare the efficacy of analgesia between Transversus Abdominis Plane Block (TAP) Block and Intraperitoneal mist instillation of Ropivacaine by assessing post-operative pain (static and dynamic) as per Numeric Rating Scale (NRS).
The secondary objective is to compare the meantime of the first dose of rescue analgesia in either group and the total supplementary analgesia required. Assessment of early recovery profile and ambulation as per ERAS protocol and to observe adverse effect related to study drug, if any.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- All
- Target Recruitment
- 134
- Patient posted for elective abdominal laparoscopic surgery needing general anaesthesia.
- Patient with American Society of anaesthesiologists (ASA) Class I and II.
- BMI more than 35 Patient with known or newly diagnosed coagulopathy Patient with history of drug allergy.
- More than one attempt at T.A.P. blockade.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the efficacy of analgesia between Transversus Abdominis Plane Block (TAP) Block and Intraperitoneal mist instillation of Ropivacaine by assessing post-operative pain (static and dynamic) as per Numeric Rating Scale (NRS). Postoperative pain score (NRS), SBP, DBP, MAP, HR and Oxygen Saturation will be recorded at 0 hours, 2 hours, 6 hours,12 hours and 24 hours after surgery.
- Secondary Outcome Measures
Name Time Method 1. To compare the meantime of the first dose of rescue analgesia in either group & the total supplementary analgesia required. 2. Assessment of early recovery profile & ambulation as per ERAS protocol.
Trial Locations
- Locations (1)
Mahatma Gandhi University of Medical Sciences and Technology
🇮🇳Jaipur, RAJASTHAN, India
Mahatma Gandhi University of Medical Sciences and Technology🇮🇳Jaipur, RAJASTHAN, IndiaAnkur SharmaPrincipal investigator7023345035ankursh@yandex.com